The Global Breast Cancer Therapeutics Market, which stood at US$ 17,868.8 Mnin 2018, will reach [US$ 38,573.5 Mn] by the end of 2026. If these figures prove true, the global breast cancer therapeutics market will rise at a CAGR of 10.2% between 2018 and 2026.
Browse Complete Report Details @
https://www.fortunebusinessinsights.com/industry-reports/breast-cancer-therapeutics-market-100163
Looming Patent Expiries Fuels Demand for Generic Drugs
According to the World Health Organization, in 2018, an approximate of 627,000 women, which is tantamount to 15% of all cancer deaths worldwide, succumbed to breast cancer. The rising incidence of breast cancer is one of the chief drivers of the global breast cancer therapeutics market.
The global breast cancer therapeutics market is likely to witness the prevalence of high competition. According to the report, Genentech, Inc. (F. Hoffmann-La Roche Ltd) held the dominant share in the market in 2018. Its diverse product portfolio backs growth of the company in a targeted and chemotherapy segment.
With the expiry of most patent drugs in the market, there is an increased demand for their generic counterparts. Such factors are propelling vendors to invest more in research and development and develop generic drugs for breast cancer treatment. The introduction of combination drug therapy is anticipated to create better growth opportunities for the Breast Cancer Therapeutics Market.
Sample PDF Brochure @
Key Segmentation of Breast Cancer Therapeutics Market:
By Therapy
By Distribution Channel
By Cancer Type
By Geography
High Intake of Oral Contraceptives Among Women, Boosting Breast Cancer Therapeutics Market
Breast cancer can develop due to reasons such as reduced breastfeeding, rise in the age of childbearing, undergoing estrogen modifying drug treatments and high intake of oral contraceptive pills. The increase in the number of women complaining of such problems and the successive rise in the number of breast cancer cases are factors boosting the global Breast Cancer Therapeutics Market for breast cancer therapeutics during the forecast period.
Another factor in creating lucrative growth opportunities for breast cancer therapies is the increasing number of obese women. With a change in lifestyle and unhealthy food habits, the rate of obesity is increasing by the day. Obesity further causes various health problems such as cardiovascular disorders, gall bladder diseases, diabetes, breathing problems, and breast cancer, among others.
Some of the Main Key Players Covered in Breast Cancer Therapeutics Market Report:
Major Table of Content for Breast Cancer Therapeutics Market:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.1 Prevalence of Breast Cancer Therapeutics by Key Countries
4.2 Regulatory Scenario byKey Regions
4.3 Key Industry Developments
4.4 Overview of Current Advances in RandD for Breast Cancer Therapeutics
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast By Therapy
5.2.1Targeted Therapy
5.2.1.1 Abemaciclib
5.2.1.2 Ado-Trastuzumab Emtansine
5.2.1.3 Everolimus
5.2.1.4 Trastuzumab
5.2.1.5 Ribociclib
5.2.1.6 Palbociclib
………….
More Trending Topics from Fortune Business Insights:
About Us
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Breast Cancer Therapeutics Market CAGR at 10.2% by Top International Players as AstraZeneca, Pfizer Inc., Sanofi & more Forecast till 2025